Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant - 09/08/11
Reprint requests: Asad Salim, MRCP, 60 Abbotts Way, Newcastle-under-Lyme, Staffordshire, ST5 2HF, UK.Staffordshire, United Kingdom
Abstract |
Background |
One previous study has shown a higher prevalence of sebaceous hyperplasia (SH) in patients with heart transplant on immunosuppressive drugs as compared with sex-matched control patients.
Objective |
We set out to compare the prevalence of SH in a cohort of patients undergoing renal transplant with age- and sex-matched control patients and to find any association with nonmelanoma skin cancer (NMSC) in these patients.
Methods |
In all, 117 patients with renal transplant and 117 age- and sex-matched control patients were screened for the prevalence of SH and NMSC.
Results |
We found that 29.9% of our patients with renal transplant had SH; 16 of 35 (45.7%) of these patients had a history of NMSC as compared with 6 of 82 (7.3%) patients without SH (P < .001, odds ratio 10.7). In the age- and sex-matched control group, a total of 28 patients (23.9%) had one or more lesions of SH.
Limitations |
This study is small and will require confirmation with larger cohort studies.
Conclusions |
In our cohort of patients with renal transplant we found a strong association of NMSC with SH. This association remained significant after correction of factors such as age, sex, skin type, and duration of transplant.
Le texte complet de cet article est disponible en PDF.Abbreviations used : CI, NMSC, OR, SH
Plan
| Funding sources: None. Conflicts of interest: None identified. |
Vol 55 - N° 5
P. 878-881 - novembre 2006 Retour au numéro
Article précédent
- Skin lightening and its complications among African people living in Paris
- Antoine Petit, Cécile Cohen-Ludmann, Philippe Clevenbergh, Jean-François Bergmann, Louis Dubertret
- Topical tacrolimus neither prevents nor abolishes ultraviolet–induced erythema
- Thilo Gambichler, Nordwig S. Tomi, Georg Moussa, Julia Huyn, Heinrich Dickel, Peter Altmeyer, Alexander Kreuter
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?